Wellington Management Group LLP acquired a new stake in OrthoPediatrics Corp. (NASDAQ:KIDS – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 314,175 shares of the company’s stock, valued at approximately $10,214,000. Wellington Management Group LLP owned approximately 1.35% of OrthoPediatrics as of its most recent SEC filing.
Other hedge funds have also recently made changes to their positions in the company. CWM LLC lifted its holdings in OrthoPediatrics by 16,283.3% in the 4th quarter. CWM LLC now owns 983 shares of the company’s stock worth $32,000 after purchasing an additional 977 shares in the last quarter. International Assets Investment Management LLC boosted its position in shares of OrthoPediatrics by 3,151.4% during the fourth quarter. International Assets Investment Management LLC now owns 1,203 shares of the company’s stock worth $37,000 after acquiring an additional 1,166 shares during the last quarter. Trust Point Inc. purchased a new position in OrthoPediatrics during the fourth quarter valued at $216,000. Premier Fund Managers Ltd bought a new stake in OrthoPediatrics in the 4th quarter valued at $264,000. Finally, Versor Investments LP bought a new position in shares of OrthoPediatrics during the 4th quarter valued at about $260,000. Institutional investors own 69.05% of the company’s stock.
Analysts Set New Price Targets
A number of equities analysts recently commented on the company. JMP Securities reissued a “market outperform” rating and set a $50.00 price target on shares of OrthoPediatrics in a research note on Tuesday, May 7th. Needham & Company LLC raised their target price on shares of OrthoPediatrics from $37.00 to $42.00 and gave the company a “buy” rating in a report on Tuesday, May 7th. Finally, Truist Financial increased their price objective on shares of OrthoPediatrics from $35.00 to $38.00 and gave the company a “hold” rating in a research report on Wednesday, May 8th.
OrthoPediatrics Stock Performance
NASDAQ:KIDS opened at $28.79 on Friday. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.99 and a current ratio of 4.45. The stock’s fifty day moving average is $31.12 and its 200 day moving average is $29.73. The firm has a market capitalization of $686.07 million, a PE ratio of -29.99 and a beta of 1.18. OrthoPediatrics Corp. has a fifty-two week low of $23.10 and a fifty-two week high of $45.96.
OrthoPediatrics (NASDAQ:KIDS – Get Free Report) last posted its quarterly earnings data on Monday, May 6th. The company reported ($0.30) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.42) by $0.12. The company had revenue of $44.69 million for the quarter, compared to analyst estimates of $41.63 million. OrthoPediatrics had a negative net margin of 13.58% and a negative return on equity of 5.12%. On average, sell-side analysts anticipate that OrthoPediatrics Corp. will post -1.2 earnings per share for the current year.
OrthoPediatrics Profile
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
See Also
- Five stocks we like better than OrthoPediatrics
- How to Invest in Insurance Companies: A GuideĀ
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- Find and Profitably Trade Stocks at 52-Week Lows
- Progress Software Stock Back in the Green After Beating Forecasts
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.